| Name | Title | Contact Details |
|---|
Metrodora Institute is the first medical and research center dedicated to advancing care and accelerating cures for people living with neuroimmune axis disorders. Our state-of-the-art, multidisciplinary institute brings together world-class clinicians, scientists, and technologists under one roof – to maximize the impact of scientific discovery and rapidly translate research into better human health outcomes. Comprehensive clinical programs integrate neurology, immunology, and gastroenterology care with genomics, pain management, comprehensive rehabilitation programs, as well as nutritional and neurocognitive therapies to provide personalized, patient-centered care. The Metrodora Model is a new blueprint for healthcare that breaks barriers between medical specialties and embeds scientific research and discovery directly in the patient care process. Together, we are leading the next frontier of science and medicine. Join our mission to accelerate the path to cures for hundreds of millions of people living with neuroimmune axis disorders.
Hair J D and Associates Inc is a Tulsa, OK-based company in the Business Services sector.
On a mission to help balance Mauiʻs invasive Axis deer populations for the good of our ecosystems and food systems. Through our singular wild-harvesting operation, we work to deliver nutrient-dense, stress-free, and wildly delicious venison to our communities and customers.
PS Detailing is a Baton Rouge, LA-based company in the Business Services sector.
Sequel Med Tech is a healthcare technology company based in Manchester, New Hampshire, dedicated to advancing drug delivery systems for diabetes management. The company focuses on creating innovative insulin delivery solutions that enhance the lives of people with diabetes. Their flagship product, the twiist™ Automated Insulin Delivery (AID) System, features advanced technology for precise insulin delivery and is designed for everyday wear. This system utilizes the Loop algorithm to automatically adjust insulin delivery, providing clinically meaningful benefits. Sequel Med Tech collaborates with healthcare providers, employers, and pharmaceutical companies to improve access to insulin therapy and develop new drug delivery solutions. They are actively working on integrating their twiist AID System with Abbott’s glucose-ketone sensor to enhance early detection of rising ketones, aiming to reduce the risk of diabetic ketoacidosis in individuals with type 1 diabetes. Through these efforts, Sequel Med Tech strives to simplify diabetes care and improve health outcomes for those who require insulin therapy.